Economic assessment of rheolytic thrombectomy versus intracoronary urokinase for treatment of extensive intracoronary thrombus: Results from a randomized clinical trial.

Cohen, D J; Ramee, S; Baim, D S; Sharma, S; Carrozza, J P; Cosgrove, R; Jones, N; Berezin, R H; Cutlip, D E; Ho, K K; Kuntz, R E

Cohen, D J; Ramee, S; Baim, D S; Sharma, S; Carrozza, J P; Cosgrove, R; Jones, N; Berezin, R H; Cutlip, D E; Ho, K K; Kuntz, R E.

Affiliation

Cohen DJ; Harvard Clinical Research Institute and the Cardiovascular Division, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA. djc@hsph.harvard.edu

Am Heart J ; 142(4): 648-56, 2001 Oct.

Article in En | MEDLINE | ID: mdl-11579355

Subject(s)

Coronary Thrombosis/drug therapy; Coronary Thrombosis/surgery; Fibrinolytic Agents/therapeutic use; Thrombectomy/economics; Thrombectomy/methods; Urokinase-Type Plasminogen Activator/therapeutic use; Angioplasty, Balloon, Coronary/economics; Angioplasty, Balloon, Coronary/methods; Coronary Thrombosis/economics; Fibrinolytic Agents/administration & dosage; Fibrinolytic Agents/economics; Health Care Costs; Hemorheology; Humans; Infusions, Intra-Arterial; Thrombectomy/instrumentation; Treatment Outcome; Urokinase-Type Plasminogen Activator/administration & dosage; Urokinase-Type Plasminogen Activator/economics

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Coronary Thrombosis / Urokinase-Type Plasminogen Activator / Thrombectomy / Fibrinolytic Agents Type of study: Clinical_trials / Health_economic_evaluation Limits: Humans Language: En Journal: Am Heart J Year: 2001 Document type: Article

Search on Google

XML

PubMed Links